Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-09-18 00:00:00 ET · period of report 2023-09-14 · accession 0001610717-23-000280 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2023-09-18 | 2023-09-14 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -3,167 | 858.9K | -0.4% | $0 |
| MT | 2023-09-18 | 2023-09-14 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $49.37 | -2,000 | 862.1K | -0.2% | -$98.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-09-14 | G | D | 3,167 | $0.00 | 858,926 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-09-14 | S | D | 1,920 | $49.35 | 862,173 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $48.78 to $49.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2023-09-14 | S | D | 80 | $49.82 | 862,093 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $49.78 to $49.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |